In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The Vaccine Market Grows Up: They're Not Just for Kids Anymore

Executive Summary

The adult vaccine market is showing more promise than ever before--and is expected to grow about as fast as pediatric vaccines--as more developers focus on diseases that afflict adults disproportionately or simply strike them in large numbers.
Advertisement

Related Content

Glaxo Buys A Stake In Intercell And Gains Access To Patch Vaccine Techology
Glaxo Buys A Stake In Intercell And Gains Access To Patch Vaccine Techology
Provenge Scores In Phase III; Will Dendreon Need To Confirm The IMPACT?
Provenge Scores In Phase III; Will Dendreon Need To Confirm The IMPACT?
Intercell Reaches Commercial Stage In US: Japanese Encephalitis Vaccine Gets FDA Okay
Intercell Reaches Commercial Stage In US: Japanese Encephalitis Vaccine Gets FDA Okay

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003349

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel